Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2953909rdf:typepubmed:Citationlld:pubmed
pubmed-article:2953909lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2953909lifeskim:mentionsumls-concept:C0040300lld:lifeskim
pubmed-article:2953909lifeskim:mentionsumls-concept:C0030847lld:lifeskim
pubmed-article:2953909lifeskim:mentionsumls-concept:C0030851lld:lifeskim
pubmed-article:2953909lifeskim:mentionsumls-concept:C0003779lld:lifeskim
pubmed-article:2953909lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:2953909lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2953909lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:2953909pubmed:issue6lld:pubmed
pubmed-article:2953909pubmed:dateCreated1987-6-29lld:pubmed
pubmed-article:2953909pubmed:abstractTextArginine vasopressin (AVP), which has been shown to have a marked contractant effect on human penile erectile tissues, particularly the corpus spongiosum (CS), was demonstrated to occur in these tissues. Out of nine CS samples, eight contained vasopressin-like immunoreactivity in concentrations ranging from 3.5 to 107.2 fmol./gm. wet weight. These amounts suggest that the hormone is taken up and/or synthesized locally. The effects of four different vasopressin antagonists were characterized on human CS strips, and they were found to effectively inhibit the contractile response to exogenous AVP. However, none of these antagonists had any effects on electrically induced contractions in penile erectile tissues. These results do not favour the view that AVP is released on electrical stimulation in amounts that contract the erectile tissues. Whether or not the peptide is involved in the mechanisms controlling penile erection remains unclear.lld:pubmed
pubmed-article:2953909pubmed:languageenglld:pubmed
pubmed-article:2953909pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2953909pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2953909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2953909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2953909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2953909pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2953909pubmed:statusMEDLINElld:pubmed
pubmed-article:2953909pubmed:monthJunlld:pubmed
pubmed-article:2953909pubmed:issn0022-5347lld:pubmed
pubmed-article:2953909pubmed:authorpubmed-author:AnderssonK...lld:pubmed
pubmed-article:2953909pubmed:authorpubmed-author:LundinSSlld:pubmed
pubmed-article:2953909pubmed:authorpubmed-author:HedlundHHlld:pubmed
pubmed-article:2953909pubmed:authorpubmed-author:FovaeusMMlld:pubmed
pubmed-article:2953909pubmed:issnTypePrintlld:pubmed
pubmed-article:2953909pubmed:volume137lld:pubmed
pubmed-article:2953909pubmed:ownerNLMlld:pubmed
pubmed-article:2953909pubmed:authorsCompleteYlld:pubmed
pubmed-article:2953909pubmed:pagination1278-82lld:pubmed
pubmed-article:2953909pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2953909pubmed:meshHeadingpubmed-meshheading:2953909-...lld:pubmed
pubmed-article:2953909pubmed:meshHeadingpubmed-meshheading:2953909-...lld:pubmed
pubmed-article:2953909pubmed:meshHeadingpubmed-meshheading:2953909-...lld:pubmed
pubmed-article:2953909pubmed:meshHeadingpubmed-meshheading:2953909-...lld:pubmed
pubmed-article:2953909pubmed:meshHeadingpubmed-meshheading:2953909-...lld:pubmed
pubmed-article:2953909pubmed:meshHeadingpubmed-meshheading:2953909-...lld:pubmed
pubmed-article:2953909pubmed:meshHeadingpubmed-meshheading:2953909-...lld:pubmed
pubmed-article:2953909pubmed:meshHeadingpubmed-meshheading:2953909-...lld:pubmed
pubmed-article:2953909pubmed:meshHeadingpubmed-meshheading:2953909-...lld:pubmed
pubmed-article:2953909pubmed:meshHeadingpubmed-meshheading:2953909-...lld:pubmed
pubmed-article:2953909pubmed:meshHeadingpubmed-meshheading:2953909-...lld:pubmed
pubmed-article:2953909pubmed:meshHeadingpubmed-meshheading:2953909-...lld:pubmed
pubmed-article:2953909pubmed:year1987lld:pubmed
pubmed-article:2953909pubmed:articleTitleCharacterization of immunoreactive arginine vasopressin (AVP) in and effects of AVP on isolated human penile erectile tissues.lld:pubmed
pubmed-article:2953909pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2953909pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed